| 07/31/2026 3:06 PM | DexCom (1093557) Subject FOLETTA MARK G (1236389) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/30/2026 4:21 PM | DexCom (1093557) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 07/30/2026 3:03 PM | DexCom (1093557) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/21/2026 3:58 PM | DexCom (1093557) Issuer SAYER KEVIN R (1286858) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/20/2026 3:05 PM | DexCom (1093557) Subject SAYER KEVIN R (1286858) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/16/2026 4:06 PM | Brown Michael Jon (1899922) Reporting DexCom (1093557) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/15/2026 3:04 PM | Brown Michael Jon (1899922) Reporting DexCom (1093557) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/07/2026 3:09 PM | DexCom (1093557) Issuer SAYER KEVIN R (1286858) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/06/2026 3:21 PM | DexCom (1093557) Subject SAYER KEVIN R (1286858) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/17/2026 3:32 PM | DexCom (1093557) Issuer FOLETTA MARK G (1236389) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2026 3:32 PM | Brown Michael Jon (1899922) Reporting DexCom (1093557) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for DXCM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for DexCom and its competitors with MarketBeat's FREE daily newsletter.
|
| 06/15/2026 4:47 PM | DexCom (1093557) Subject FOLETTA MARK G (1236389) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/15/2026 3:01 PM | Brown Michael Jon (1899922) Reporting DexCom (1093557) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/05/2026 3:17 PM | Coleman Jon (1442689) Reporting DexCom (1093557) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2026 3:03 PM | Coleman Jon (1442689) Reporting DexCom (1093557) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/01/2026 4:34 PM | DexCom (1093557) Issuer GALA RENEE D (1607737) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/01/2026 4:34 PM | Collins Richard Alexander (1700619) Reporting DexCom (1093557) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/01/2026 4:34 PM | Ashley Euan A. (2092523) Reporting DexCom (1093557) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/01/2026 4:34 PM | DexCom (1093557) Issuer Driscoll Rimma (1952575) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/01/2026 4:34 PM | DexCom (1093557) Issuer Osterloh Albert Frederick IV (2111108) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/01/2026 4:34 PM | DexCom (1093557) Issuer Heller Bridgette P (1485616) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/01/2026 4:34 PM | DexCom (1093557) Issuer FOLETTA MARK G (1236389) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/01/2026 4:34 PM | AUGUSTINOS NICHOLAS (1238485) Reporting DexCom (1093557) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/01/2026 4:35 PM | DexCom (1093557) Issuer Malady Kyle (1760581) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/01/2026 4:35 PM | ALTMAN STEVEN R (1191307) Reporting DexCom (1093557) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/28/2026 4:15 PM | DexCom (1093557) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/27/2026 3:38 PM | Coleman Jon (1442689) Reporting DexCom (1093557) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/27/2026 3:39 PM | DexCom (1093557) Issuer Stern Sadie (1797971) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/27/2026 3:39 PM | DexCom (1093557) Issuer Sylvain Jereme M (1681267) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/27/2026 3:39 PM | Brown Michael Jon (1899922) Reporting DexCom (1093557) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/27/2026 3:39 PM | DexCom (1093557) Issuer Leach Jacob Steven (1700255) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 3:18 PM | DexCom (1093557) Issuer SAYER KEVIN R (1286858) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/21/2026 4:05 PM | DexCom (1093557) Subject SAYER KEVIN R (1286858) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/19/2026 3:34 PM | Brown Michael Jon (1899922) Reporting DexCom (1093557) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/14/2026 3:39 PM | DexCom (1093557) Issuer Heller Bridgette P (1485616) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/12/2026 8:47 AM | DexCom (1093557) Subject Heller Bridgette P (1485616) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/11/2026 6:13 PM | ALTMAN STEVEN R (1191307) Reporting DexCom (1093557) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 6:13 PM | DexCom (1093557) Issuer FOLETTA MARK G (1236389) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 6:13 PM | Collins Richard Alexander (1700619) Reporting DexCom (1093557) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 6:13 PM | AUGUSTINOS NICHOLAS (1238485) Reporting DexCom (1093557) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/30/2026 4:20 PM | DexCom (1093557) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
Trump Takes Emergency Action - Plus Elon Musk's New Venture (Ad) Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states.
The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now. See which companies control the supply chain behind this emerging tech |
| 04/29/2026 5:24 PM | DexCom (1093557) Subject VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by | Form SCHEDULE 13G | |
| 04/29/2026 11:51 AM | DexCom (1093557) Subject VANGUARD PORTFOLIO MANAGEMENT LLC (2100121) Filed by | Form SCHEDULE 13G | |
| 04/16/2026 6:27 PM | Brown Michael Jon (1899922) Reporting DexCom (1093557) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/15/2026 3:11 PM | DexCom (1093557) Filer | Form DEF 14A | |
| 04/15/2026 3:13 PM | DexCom (1093557) Filer | Form DEFA14A | |
| 04/15/2026 3:14 PM | DexCom (1093557) Filer | Form ARS | |
| 04/15/2026 3:06 PM | Brown Michael Jon (1899922) Reporting DexCom (1093557) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/26/2026 5:02 PM | DexCom (1093557) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/16/2026 3:02 PM | Brown Michael Jon (1899922) Reporting DexCom (1093557) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/26/2026 3:32 PM | DexCom (1093557) Issuer Osterloh Albert Frederick IV (2111108) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/12/2026 4:20 PM | DexCom (1093557) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/12/2026 8:51 AM | DexCom (1093557) Subject Heller Bridgette P (1485616) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/02/2026 3:46 PM | DexCom (1093557) Issuer SAYER KEVIN R (1286858) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/02/2026 3:46 PM | Brown Michael Jon (1899922) Reporting DexCom (1093557) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/02/2026 3:46 PM | DexCom (1093557) Issuer Sylvain Jereme M (1681267) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/02/2026 3:46 PM | DexCom (1093557) Issuer Stern Sadie (1797971) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/02/2026 3:46 PM | DexCom (1093557) Issuer Leach Jacob Steven (1700255) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 6:30 AM | DexCom (1093557) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/22/2025 3:35 PM | DexCom (1093557) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/17/2025 4:52 PM | Collins Richard Alexander (1700619) Reporting DexCom (1093557) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/12/2025 4:14 PM | DexCom (1093557) Issuer Heller Bridgette P (1485616) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/12/2025 9:52 AM | DexCom (1093557) Subject Heller Bridgette P (1485616) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/10/2025 6:12 PM | Collins Richard Alexander (1700619) Reporting DexCom (1093557) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/10/2025 6:13 PM | DexCom (1093557) Issuer Leach Jacob Steven (1700255) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/10/2025 8:52 AM | Collins Richard Alexander (1700619) Reporting DexCom (1093557) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/30/2025 4:19 PM | DexCom (1093557) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/30/2025 1:56 PM | DexCom (1093557) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 10/28/2025 3:47 PM | Ashley Euan A. (2092523) Reporting DexCom (1093557) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 10/28/2025 3:49 PM | Ashley Euan A. (2092523) Reporting DexCom (1093557) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/27/2025 3:15 PM | DexCom (1093557) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/09/2025 3:18 PM | DexCom (1093557) Issuer Malady Kyle (1760581) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/05/2025 10:08 AM | DexCom (1093557) Subject Malady Kyle (1760581) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/04/2025 3:29 PM | DexCom (1093557) Subject Stern Sadie (1797971) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/18/2025 4:53 PM | DexCom (1093557) Issuer FOLETTA MARK G (1236389) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2025 4:56 PM | Brown Michael Jon (1899922) Reporting DexCom (1093557) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/15/2025 3:57 PM | Brown Michael Jon (1899922) Reporting DexCom (1093557) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |